Skip Navigation LinksHome > Editorial Board

Editorial Board

Editor-in-Chief

Steven L. Lewis, MD, FAAN
Associate Chair, Professor, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois

Relationship Disclosure: Dr Lewis has received personal compensation from the AAN for serving as Editor-in-Chief of Continuum: Lifelong Learning in Neurology and as section co-editor for continuing medical education for Neurology. Dr Lewis has received royalty payments from Wolters Kluwer for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist from Wiley-Blackwell for the book Neurological Disorders Due to Systemic Disease.

Associate Editor

Charles Zollinger, MD
Adult Neurologist, NeuroCare Center Inc., Canton, Ohio; Clinical Assistant Professor of Internal Medicine, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Rootstown, Ohio

Relationship Disclosure: Dr Zollinger performs cognitive assessments on a trial sponsored by Merck & Co, Inc. He is a partner at NeuroCare Center, Inc, which collaborates with Ohio Clinical Research Partners to participate in other clinical trials.

Associate Editor of Ethics

Daniel G. Larriviere, MD, JD, FAAN

Interim Chair of Neurology and Residency Program Director, Ochsner Neuroscience Institute, New Orleans, Louisiana

Relationship Disclosure: Dr Larriviere has served as a course faculty member for the AAN, is a paid faculty member of the American Academy for the Advancement of Science, and serves as an associate editor of Continuum Audio.

Associate Editor of Practice

Anna D. Hohler , MD, FAAN
Assistant Professor of Neurology, Boston University Medical Campus, Boston, Massachusetts

Relationship Disclosure: Dr Hohler has received personal compensation for activities with Teva Neuroscience.

Associate Editor of Coding

Laura B. Powers, MD, FAAN
Retired from private practice

Relationship Disclosure: Dr Powers serves as ICD-9-CM Advisor for the Coding Subcommittee of the AAN Medical Economics and Management Committee and serves in an editorial capacity for Neurology: Clinical Practice.

Associate Editor of Child Neurology

Jonathan W. Mink, MD, PhD, FAAN
Professor of Neurology, Neurobiology and Anatomy, Brain and Cognitive Sciences, and Pediatrics; Chief, Division of Child Neurology; Vice Chair, Department of Neurology, University of Rochester Medical Center, Rochester, New York

Relationship Disclosure:Dr Mink has received personal compensation for activities with Edison Pharmaceuticals and serves in an editorial capacity for Neurology.

Continuum Audio Editor

Aaron E. Miller, MD, FAAN
Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology, Mount Sinai School of Medicine, New York, New York

Relationship Disclosure: Dr Miller has received personal compensation for consulting and/or speaking activities from Accordant Health Services; Acorda Therapeutics; Biogen Idec; EMD Serono; GlaxoSmithKline; Merck Serono; Novartis Corporation; Nuron Biotech, Inc; ONO Pharmaceutical Co, Ltd; Sanofi-Aventis; and Teva Neuroscience. Dr Miller has received personal compensation from the AAN for serving as editor of Continuum Audio.Dr Miller has received research support for participation in clinical trials from Acorda Therapeutics; Biogen Idec; Genentech, Inc; Genzyme Corporation; Novartis Corporation; Hoffmann-La Roche, Inc; Sanofi-Aventis; and Teva Neuroscience.

Consulting Pharmacist

Marketa Marvanova, PharmD, PhD, CGP
Associate Professor of Pharmacy Practice, Chicago State University College of Pharmacy, Chicago, Illinois

Relationship Disclosure: Dr Marvanova reports no disclosure.

Editorial Board

Hannah R. Briemberg, MD
Director, Neurology Residency Program; Clinical Assistant Professor, The University of British Columbia
Relationship Disclosure: Dr Briemberg reports no disclosure.

Cynthia L. Comella, MD, FAAN
Professor of Neurology, Rush University Medical Center, Chicago, Illinois
Relationship Disclosure: Dr Comella has served as a consultant for Allergan, Inc; Ipsen; Medtronic Corporation; Merz Pharma; Teva Neuroscience; and WorldMeds. Dr Comella receives research support from Allergan, Inc; Dystonia Study Group; Ipsen; Merz, Inc; and the NIH.

Carlayne E. Jackson, MD, FAAN
Professor of Neurology and Otolaryngology, Assistant Dean for Ambulatory Services, Chief Medical Officer, UT Medicine, University of Texas Health Science Center, San Antonio, Texas
Relationship Disclosure: Dr Jackson receives research support from WorldMeds and Questcor Pharmaceuticals, Inc.

Joseph S. Kass, MD, JD
Associate Professor of Neurology, Psychiatry, and Medical Ethics; Director, Neurology Residency Program; Chief of Neurology Service, Ben Taub General Hospital, Baylor College of Medicine, Houston, Texas
Relationship Disclosure: Dr Kass reports no disclosure.

Shannon M. Kilgore, MD
Clinical Assistant Professor, Stanford University; Assistant Chief of Neurology, VA Palo Alto Health Care System, Palo Alto, California
Relationship Disclosure: Dr Kilgore reports no disclosure.

Laszlo Mechtler, MD
Professor, Chief of Department of Neuro-oncology, Roswell Park Cancer Institute, Buffalo, New York; Clinical Associate Professor of Neurology, School of Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Vice President, Director, Brain Tumor Center, Director, Headache Clinic, Dent Neurologic Institute, Amherst, New York
Relationship Disclosure: Dr Mechtler has received personal compensation for activities with Allergan, Inc; Forest Laboratories, Inc; GlaxoSmithKline; Merck & Co, Inc; Nautilus Neurosciences, Inc; and Zogenix, Inc. Dr Mechtler has received research support from Celldex Therapeutics; GlaxoSmithKline; Pharmanet Group, Ltd; Spectrum Pharmaceuticals, Inc; and St Jude Medical.

Joseph E. Safdieh, MD
Associate Professor of Neurology (Education), Weill Cornell Medical College, New York, New York; Vice Chairman of Neurology for Education, New York Presbyterian–Weill Cornell Medical Center, New York, New York
Relationship Disclosure: Dr Safdieh receives research support from Accera, Inc, and serves on the speakers bureau for Supernus Pharmaceuticals, Inc.

Erik K. St. Louis, MD, FAAN
Head, Section of Sleep Neurology; Consultant, Departments of Neurology and Medicine; Associate Professor of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota
Relationship Disclosure: Dr St. Louis serves as a member of the Adverse Events Adjudication Committee of Inspire, Inc, and receives research support from Mayo Clinic and Foundation, National Institute of Aging, and NIH.

Past Editor

Aaron E. Miller, MD, FAAN (2003-2012)

Founding Program Director

Theodore L. Munsat, MD, FAAN

Editorial Offices

Main Office
Continuum: Lifelong Learning in Neurology
American Academy of Neurology
201 Chicago Avenue
Minneapolis, MN 55415
Phone: (612) 928-6000; (800) 879-1960
Fax: (612) 454-2749

Editor-in-Chief’s Office
Department of Neurological Services
Rush University Medical Center
1725 West Harrison Street, Suite 1106
Chicago, IL 60612
Phone: 312-942-4500
Fax: 312-942-2380

Editorial Staff

Executive Editor
Andrea J. Weiss, MA
Relationship Disclosure: Ms Weiss reports no disclosure.
Email: aweiss@aan.com

Program Manager
Amanda Doering Tourville
Relationship Disclosure: Ms Tourville reports no disclosure.
Email: atourville@aan.com

Senior Administrator
Missy Render, MS
Relationship Disclosure: Ms Render reports no disclosure.
Email: mrender@aan.com